Position in LLY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$2,958,994
+$1,168,202 QoQ
Shares Held
2,467
+26.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.57%
of 13F equity value
Holder Rank
#2,140
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026S.A. Mason LLC holds $12,379,971 across 9 Drug Manufacturers - General names. LLY ranks #2 (23.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
12,339 | $3,104,985 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
2,467 | $2,958,994 | |
| 3 | AMGN |
Amgen Inc
|
6,408 | $2,320,464 | |
| 4 | JNJ |
Johnson & Johnson
|
7,845 | $1,992,394 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,968 | $638,388 | |
| 6 | NVS |
Novartis AG
|
4,040 | $633,148 | |
| 7 | NVO |
Novo Nordisk A S
|
6,278 | $300,967 | |
| 8 | PFE |
Pfizer Inc
|
9,104 | $219,224 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,958,994 | 2,467 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,790,792 | 1,947 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $2,088,103 | 1,943 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,482,509 | 1,943 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $1,514,626 | 1,943 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $1,605,569 | 1,944 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,500,768 | 1,944 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $1,722,267 | 1,944 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,760,058 | 1,944 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $1,405,773 | 1,807 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $1,041,095 | 1,786 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $940,514 | 1,751 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $821,183 | 1,751 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $601,328 | 1,751 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $640,585 | 1,751 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $566,185 | 1,751 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $567,726 | 1,751 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $501,433 | 1,751 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $483,661 | 1,751 | Shares | Sole | 2022-01-04 | |
| 2021-09-30 | $404,568 | 1,751 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $401,889 | 1,751 | Shares | Sole | 2021-07-07 | |
| 2021-03-31 | $327,121 | 1,751 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $295,638 | 1,751 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $263,623 | 1,781 | Shares | Sole | 2020-10-21 | |
| 2020-06-30 | $287,479 | 1,751 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $284,514 | 2,051 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||